2021
DOI: 10.1186/s13059-021-02573-y
|View full text |Cite
|
Sign up to set email alerts
|

Author Correction: The SEQC2 epigenomics quality control (EpiQC) study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 1 publication
(1 reference statement)
0
1
0
Order By: Relevance
“…As such, the opportunities for obtaining DNA methylation pro les of clinical samples are expected to further increase. Although it is technically possible to obtain DNA methylation information in a genomewide manner by the methods such as EM-seq (6) and long-read HiFi sequencing (7), it is currently not practical cost-wise to apply such methods to hundreds to thousands of samples. Targeted capture methylation sequencing (methyl-seq) signi cantly reduces per-sample costs and is expected to remain as one of the methods for clinical methylome analyses for the time being.…”
Section: Introductionmentioning
confidence: 99%
“…As such, the opportunities for obtaining DNA methylation pro les of clinical samples are expected to further increase. Although it is technically possible to obtain DNA methylation information in a genomewide manner by the methods such as EM-seq (6) and long-read HiFi sequencing (7), it is currently not practical cost-wise to apply such methods to hundreds to thousands of samples. Targeted capture methylation sequencing (methyl-seq) signi cantly reduces per-sample costs and is expected to remain as one of the methods for clinical methylome analyses for the time being.…”
Section: Introductionmentioning
confidence: 99%